Skip to main content
OpenTrials

Clinical trial condition

Stage IB-IIB Cutaneous T-Cell Lymphoma

Explore clinical trials studying Stage IB-IIB Cutaneous T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Stage IB-IIB Cutaneous T-Cell Lymphoma trial results

Recruiting

Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma

NCT04128072

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University Hospitals Copenhagen - Rigshospitalet Copenhagen, Denmark
  • CHU de Bordeaux - Groupe Hospitalier Saint-Andre - Hopital Saint-Andre Bordeaux, France
  • Assistance Publique Hopitaux Paris- APHP Nord - Univ De Paris Cite - Hop. Saint Louis Paris, France
  • UniversitaetsMedizin Mannheim Mannheim, Germany
View all 13 locations
View Trial Details

Related conditions